Kumar Shukla / Pandey / Dixit Gallbladder Cancer

Current Treatment Options
2023
ISBN: 978-981-19-6442-8
Verlag: Springer Singapore
Format: PDF
Kopierschutz: 1 - PDF Watermark

E-Book, Englisch, 349 Seiten, eBook

The book discusses the recent progress in understanding the therapeutic targets for gallbladder cancer to provide opportunities for research and for developing innovative strategies that may enhance the benefit of conventional chemotherapy. The book focuses on identifying candidate molecules and the overall status of the targeted therapies available for gallbladder cancer, as there is an urgent need to discover new molecular targets that can guide the emergence of new treatment strategies to improve patient outcomes and act as biomarkers for the early detection of diseases. Recently, new treatment therapeutics targets for gallbladder cancer patients have been identified and the field is evolving rapidly. The book is relevant for the clinical researcher, surgeon, scientist and academician.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Kumar Shukla, Vijay

Pandey, Manoj

Dixit, Ruhi

Inhaltsverzeichnis

Gallbladder Cancer: Current treatment options and therapeutics.- Surgical Management of Gallbladder Cancer Patients.- Conventional therapy in Gallbladder Cancer.- Adjuvant Therapy following Surgical Treatment of Gallbladder Cancer.- Incidental gallbladder cancer: the role of routine versus selective histopathological examination of gallbladder specimens after cholecystectomy.- Minimally Invasive Surgery for Management of Gallbladder Cancer.- Thickwalled Gallbladder: Differential diagnosis and surgical approach to a thickened gallbladder.- Management of incidentally detected gallbladder cancer after cholecystectomy.- Adjuvant treatment in radically resected gallbladder cancer.- A look at emerging therapeutic targets for gallbladder cancer: a multi-omics approach.- MicroRNA and their role in Carcinoma Gallbladder.- Gallbladder cancer: Epigenetic landscape, Targeted therapy and Prospect of Epitherapy.- Targeted treatment of Gallbladder cancer.- Molecular pathways in Gallbladder cancer aspotential therapeutic target.- Targeted Therapy: Molecular Pathology and Targets of Gallbladder Cancer.- Targeted Therapies in Gallbladder Cancer: Current Status and Future Perspectives.- Integrative omics - the roadmap for gallbladder biomarkers identification.- Anti-EGFR Therapy in Gall Bladder Cancer.

Über Autor(innen)

Dr. Vijay Kumar Shukla  is Rector, Banaras Hindu University and Professor in the Department of General Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India. Dr. Shukla is internationally known for his research on gallbladder cancer and wound healing. He had been the visiting Professor at reputed international universities/medical schools. He has been honored with several national and international awards, including the Life Time Achievement Award at the World Union of Wound Healing Societies in Toronto, Canada, in 2008, for his exemplary work in wound healing and research. He was awarded the Fellow of the College of Wound Care Specialist (FCWCS), Malaysia, in 2017 and a fellowship of the National Academy of Medical Sciences in 2007. In his illustrious career, Prof. Shukla has been the President of the Indian Society of Wound Management, Member of the ICMR task force on gallbladder cancer, Examiner and Inspector of the National Board of Examination, Vice-president, Hernia Society of India, Executive member, Association of Colon and Rectal Surgeons of India, Governing Council Member of ASI, Member, Independent Innovators Expert panel of Ministry of Health and Family Welfare, Govt. of India. He hosted the ASICON 2006 at Varanasi as Organizing Secretary. He has been a member of 12 national and international professional bodies and has published 470 papers in International and National Journals.Dr. Manoj Pandey  is a Professor in the Department of Surgical Oncology, Institute of Medical Sciences, Banaras Hindu University, Varanasi and Visiting Professor of the Department of Surgical Oncology, AIIMS, Rishikesh, Uttrakhand. He has served as the Director of Bhopal Memorial Hospital and Research Centre and National Institute for Research in Environmental Health, Indian Council of Medical Research. His research publications reflect his expertise in gallbladder cancer research and his aspiration for quality research. He has published more than 328 publications. He has been honored with several awards, including Dr. U C Gupta Memorial Award for Excellence in Surgery. Dr. Pandey has also been a member of the task force of ICMR on the review of cancer management. Dr. Ruhi Dixit  works as a Women Scientist in the Department of General Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India. She has a keen interest in cancer research and has been working on gallbladder cancer. She has published in various journals of international reputation. Moreover, she has served as a reviewer of a reputed double-blind referred international journal. To perform cutting-edge research, she has also participated in various hands-on trainings and workshops in related areas and has presented her novel findings on reputed international platforms. She is currently working on the development of diagnostic biomarkers for gallbladder cancer.